The compromised tumor suppression observed in patients with DDX41 variants may be related to disruption of pre-mRNA splicing, RNA processing, small nucleolar RNA processing, or ribosome biogenesis (Chlon et al. 2021; Polprasert et al. 2015), implicating the normal function of DDX41 in these crucial biological processes. Here, DDX41 is linked to neoplasm.